Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy

By Morales E.   Andres A.   Gonzalez E.   Herrero J.C.   Munoz M.A.   Ortiz M.   Espejo B.   Lumbreras C.   Morales J.M.   Aguado J.M.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 73-74

Elsevier

Access to resources Recommend Favorite

Ganciclovir Prophylaxis of Cytomegalovirus Disease

By Conti D.J.   Shen G.   Singh T.   Isenberg A.   Freed B.M.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 804-806

Elsevier

Access to resources Recommend Favorite

Acyclovir prophylaxis of cytomegalovirus disease in kidney transplant recipients

By Vila A.   Guirado L.L.   Balius A.   Daz M.   Baro E.   Olaya M.   Andrade M.   Agraz I.   Sola R.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2335-2336

Elsevier

Access to resources Recommend Favorite

Failure of Ganciclovir Prophylaxis of Primary Cytomegalovirus Disease in Immunologic High-Risk Recipients

By Conti D.J.   Isenberg A.   Shen G.K.   Hahn A.   Singh T.P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1314-1315

Elsevier

Access to resources Recommend Favorite

Superior Efficacy of Oral Ganciclovir Over Oral Acyclovir for Cytomegalovirus Prophylaxis in Kidney-Pancreas and Pancreas Alone Recipients

By Somerville T.   Hurst G.   Alloway R.   Gaber A.   Shokouh-Amiri M.H.   Stratta R.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1546-1548

Elsevier

Access to resources Recommend Favorite